Barclays
CLLS

Barclays’s Cellectis CLLS Stock Holding History

Barclays’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-224
Closed -$710 – 5381
2026
Q1 		$710 Buy
+224
New +$859 ﹤0.01% 4920
2023
Q4 		– Sell
-28
Closed -$44 – 5236
2023
Q3 		$44 Hold
28
– – ﹤0.01% 4558
2023
Q2 		$55 Hold
28
– – ﹤0.01% 4456
2023
Q1 		$54 Hold
28
– – ﹤0.01% 5013
2022
Q4 		$59 Sell
28
-622
-96% -$1.41K ﹤0.01% 5209
2022
Q3 		$1K Buy
+650
New +$1.97K ﹤0.01% 4679
2022
Q1 		– Sell
-2,324
Closed -$19K – 5018
2021
Q4 		$19K Sell
2,324
-41,264
-95% -$406K ﹤0.01% 3954
2021
Q3 		$549K Sell
43,588
-19,801
-31% -$274K ﹤0.01% 3141
2021
Q2 		$980K Buy
63,389
+40,173
+173% +$675K ﹤0.01% 2670
2021
Q1 		$469K Buy
23,216
+18,688
+413% +$462K ﹤0.01% 3215
2020
Q4 		$123K Buy
4,528
+4,043
+834% +$90.7K ﹤0.01% 4034
2020
Q3 		$9K Buy
+485
New +$8.61K ﹤0.01% 5023
2020
Q1 		– Sell
-71
Closed -$1K – 6164
2019
Q4 		$1K Sell
71
-290
-80% -$3.87K ﹤0.01% 6270
2019
Q3 		$4K Buy
361
+260
+257% +$3.5K ﹤0.01% 6471
2019
Q2 		$2K Sell
101
-1,131
-92% -$20.2K ﹤0.01% 6791
2019
Q1 		$23K Buy
1,232
+1,145
+1,316% +$20.3K ﹤0.01% 6292
2018
Q4 		$1K Buy
87
+1
+1% +$23 ﹤0.01% 6783
2018
Q3 		$2K Sell
86
-4,760
-98% -$137K ﹤0.01% 6929
2018
Q2 		$137K Sell
4,846
-6
-0.1% -$179 ﹤0.01% 5035
2018
Q1 		$152K Buy
4,852
+52
+1% +$1.64K ﹤0.01% 5066
2017
Q4 		$140K Sell
4,800
-10,300
-68% -$281K ﹤0.01% 4976
2017
Q3 		$430K Buy
+15,100
New +$391K ﹤0.01% 3767
2015
Q2 		– Sell
-90
Closed -$3K – 7028
2015
Q1 		$3K Buy
+90
New +$3.27K ﹤0.01% 6757

Other funds holding CLLS

BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays's CLLS Position: Q2 2026 in Review

Barclays sold out of Cellectis (CLLS) in Q2 2026, closing a stake of 224 shares — an estimated $710 sold.

Barclays first reported a position in CLLS in Q1 2015 and held it in 23 quarters. The position peaked at $980K in Q2 2021. 27 funds tracked by Wall St. Rank hold CLLS as of Q2 2026.

  • Barclays reported no remaining Cellectis position as of Q2 2026 after selling out during the quarter.
  • Barclays sold 224 Cellectis shares in Q2 2026, an estimated $710.
  • Barclays first reported a position in Cellectis in Q1 2015 and held it in 23 quarters.
  • Barclays's Cellectis position peaked at $980K in Q2 2021.
  • 27 funds tracked by Wall St. Rank held Cellectis as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.